Article and Video CATEGORIES

Cancer Journey

Search By

Challenges of Pneumonectomy Surgery
Author
GRACE Videos and Articles
GRACE Cancer Video Library - Lung

GCVL_LU-D05_Pneumonectomy_Surgery_Challenges

 

Dr. Eric Vallières, thoracic surgeon, describes the phsycial challenges and risks for patients who undergo a pneumonectomy for lung cancer.

[

]

Download Transcript

[ratingwidget post_id=0]

Please feel free to offer comments and raise questions in our Discussion Forums.

 

Transcript

The pneumonectomy, which I’ve described as when you remove the entire lung, for most patients is, physiologically, a bigger challenge. It is also a more risky operation; in general, patients who undergo a pneumonectomy — their risk of operative death, meaning dying as a result of surgery in the next 30 to 90 days, is three to four times higher than if they had only required a lobectomy. So the more lung you remove, the higher the risk.

GCVL_LU-D05_Pneumonectomy_Surgery_Challenges ML.001

Now, that’s not true for everyone. If someone comes to us and they already have a tumor that is completely occluding their lung, and they’ve been living like this for months, for us to go in and remove that lung — they’ve already shown everyone, including themselves, that they don’t need that lung, they’re living fine. But for someone who is utilizing that lung, for a significant portion, and when in the operating room you just take it out in one swoop, that is a physiological challenge, and that’s something that we have to evaluate seriously.

So the mortality is higher, and the complication rates of a pneumonectomy are also higher — two to three times higher, so it is a bigger challenge to take someone through a pneumonectomy short-term, and long-term. There is evidence now that there are a significant number of patients where they may survive the operation, but two years, three years, five years down the line, the fact that they only have one lung takes a toll on them, and there are some long-term issues for some patients — not all, but for some patients, in having undergone what’s called a pneumonectomy.

Interestingly enough, a left pneumonectomy is not as challenging to the patient, nor to the surgeon, as a right pneumonectomy. Our right lung is a bigger lung, and losing your right lung, in general, it’s not universal, is more of a challenge that losing the left lung.

GCVL_LU-D05_Pneumonectomy_Surgery_Challenges ML.002b

There is an alternative for some patients to pneumonectomy, and that’s called a sleeve resection. Now, a sleeve resection is an operation where the tumor that you’re removing is fairly central, and what you do is you cut the airway above the tumor, cut the airway below the tumor, take out the tumor and the lobe — usually the upper lobe on either side, and then you reimplant the bottom part of the lung to where you cut things up. That’s a good alternative, oncologically — so as far as cancer results, it’s as good as a pneumonectomy. But it is physiologically, in the long run, a much better operation for the patients. Some patients who are considered for a pneumonectomy are candidates for these sleeve type of resections, which are done in centers of excellence, but that’s something to be aware of.

Next Previous link

Previous PostNext Post

Related Content

Article
Advance directives are a powerful way to take control of healthcare choices. These documents allow you to outline preferences for medical care and specify end-of-life wishes. These documents can also be a way to appoint loved ones who you would like to help with these decisions, such as a healthcare proxy (someone to make decisions on your behalf, if you cannot). As cancer treatments can involve aggressive treatments and/or complex medical management, having advance directives ensures that your desires regarding treatment options and end-of-life care are clearly communicated. 
Image
2024-25 patient perspectives header
Article
Tell your story and help us help others! Apply online now for this paid opportunity. This program gives a voice to those who have experience in participating in a clinical trial for a cancer diagnosis. Your voice helps to educate and advocate for others who are in or who may be considering a clinical trial.  We want to hear from you!
Image
Foro de Pacientes de Terapias Dirigidas de Cáncer de Pulmón
Video
¡El vídeo completo bajo demanda está disponible para verlo!

Forum Discussions

Hi elysianfields and welcome to Grace.  I'm sorry to hear about your father's progression. 

 

Unfortunately, lepto remains a difficult area to treat.  Recently FDA approved the combo Lazertinib and Amivantamab...

Hello Janine, thank you for your reply.

Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...

Hi elysianfields,

 

That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...

Recent Comments

JOIN THE CONVERSATION
I could not find any info on…
By JanineT GRACE … on
Hi elysianfields,

 

That's…
By JanineT GRACE … on
Hello Janine, thank you for…
By elysianfields on
EGFR
By happybluesun on